FDA Investigator: Claudia M. Perez-Kasmarski
- Claudia M. Perez-Kasmarski first started conducting FDA inspections in 2019, with the last inspection in 2024. Over that time, Claudia M. Perez-Kasmarski has conducted 23 inspections at 23 companies across 23 sites.
Get Claudia Perez-Kasmarski's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Bausch Health Americas, Petaluma | April 2024
Available Now - $199
Claudia M. Perez-Kasmarski
Human Drugs Form 483
FDA 483 RADIANCE BEAUTY & WELLNESS, Chatsworth | April 2023
Available Now - $199
Claudia M. Perez-Kasmarski
Human Drugs Form 483
483 Response RADIANCE BEAUTY & WELLNESS, Chatsworth | 2023
Available Now - $299
Claudia M. Perez-Kasmarski
Human Drugs Form 483
FDA 483 ACTA Laboratories, Foothill Ranch | February 2023
Available Now - $199
Claudia M. Perez-Kasmarski
Human Drugs Form 483
FDA 483 FNC Medical, Ventura | December 2022
Available Now - $199
Claudia M. Perez-Kasmarski
Human Drugs Form 483
FDA 483 Cosmoceutical Research Center, Panorama City | 2022
Available Now - $199
Claudia M. Perez-Kasmarski
Human Drugs Form 483
FDA 483 Defender SD Manufacturing, San Diego | September 2022
Available Now - $199
Claudia M. Perez-Kasmarski
Human Drug Form 483
FDA 483 Green Wave Analytical, San Diego | March 2022
Available Now - $199
Claudia M. Perez-Kasmarski
Human Drug Form 483
FDA 483 Genlabs, Chino | December 2021
Available Now - $199
Claudia M. Perez-Kasmarski
Human Drug Form 483
FDA 483 NuSil Technology, Bakersfield | July 2021
Available Now - $199
Claudia M. Perez-Kasmarski
Human Drug Form 483
FDA 483 Clinical Resolution Laboratory, Brea | April 2021
Available Now - $199
Claudia M. Perez-Kasmarski
Human Drug Form 483
FDA 483 Soaptronic, Lake Forest | February 2020
Available Now - $199
Claudia M. Perez-Kasmarski
Human Drug Form 483
FDA 483 Jiangxi Tianxin Pharmaceutical Co., Ltd., Leping | 2024
Out-of-stock
Claudia M. Perez-Kasmarski
Human Drugs Form 483
FDA 483 Pharmadepot Labs, LLC, San Diego | 2024
Out-of-stock
Claudia M. Perez-Kasmarski
Human Drugs Form 483
FDA 483 Innovation Specialties, Inc., Culver City | 2023
Out-of-stock
Claudia M. Perez-Kasmarski
Human Drugs Form 483
FDA 483 RB Salute Mexico SA de CV, Coyoacan | 2023
Out-of-stock
Claudia M. Perez-Kasmarski
Human Drugs Form 483
FDA 483 Laboratorios Liomont, S.A. de C.V., Ciudad De Mexico | 2023
Out-of-stock
Claudia M. Perez-Kasmarski
Human Drugs Form 483
FDA 483 Organo Sintesis, S.A. De C.V., Capulhuac | 2023
Out-of-stock
Claudia M. Perez-Kasmarski
Human Drugs Form 483
FDA 483 Chemcor Chemical Corp, Chino | 2022
Out-of-stock
Claudia M. Perez-Kasmarski
Human Drug Form 483
FDA 483 O.C.C.S. Inc., Stanton | 2022
Out-of-stock
Claudia M. Perez-Kasmarski
Human Drug Form 483
FDA 483 Pyramid Laboratories, Inc., Costa Mesa | 2021
Out-of-stock
Claudia M. Perez-Kasmarski
Human Drug Form 483
Co-Investigators (17)
- Navneet Kaur,
- Muna Algharibeh, FDA Investigator
- Amir Alavi, FDA Investigator
- Andrew Le, FDA Investigator
- Bryan A. Galvez, FDA Investigator
- Gavin T. Cua, FDA Investigator
- Lisa Shin, FDA Investigator
- Santiago Gallardo Johnson, FDA Investigator
- Gallardo Johnson, Santiago, FDA Investigator
- Miguel A. Martinez, FDA Investigator
- Scott N. Lim, FDA Investigator
- Alan L. Truong, FDA Investigator
- Truong X. Nguyen, FDA Investigator
- Rumany C. Penn, FDA Investigator
- James A. Barreto, FDA Investigator
- Patricia F. Alberico, FDA Investigator
- Michael D. Kawalek, FDA Investigator